CONTOUR NEXT BLOOD GLUCOSE METER

Glucose Dehydrogenase, Glucose

BAYER HEALTHCARE LLC

The following data is part of a premarket notification filed by Bayer Healthcare Llc with the FDA for Contour Next Blood Glucose Meter.

Pre-market Notification Details

Device IDK121190
510k NumberK121190
Device Name:CONTOUR NEXT BLOOD GLUCOSE METER
ClassificationGlucose Dehydrogenase, Glucose
Applicant BAYER HEALTHCARE LLC 555 WHITE PLAINS RD. Tarrytown,  NY  10591
ContactCharles Ryan
CorrespondentCharles Ryan
BAYER HEALTHCARE LLC 555 WHITE PLAINS RD. Tarrytown,  NY  10591
Product CodeLFR  
Subsequent Product CodeJJX
Subsequent Product CodeNBW
CFR Regulation Number862.1345 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeSpecial
3rd Party ReviewedNo
Combination ProductNo
Date Received2012-04-19
Decision Date2012-07-26
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
40301939697018 K121190 000
40301937278707 K121190 000
50301937314013 K121190 000
50301937315010 K121190 000
40301937308503 K121190 000
40301937357501 K121190 000
40301939735253 K121190 000
40301939736502 K121190 000
40301939737219 K121190 000
10301937313100 K121190 000
40301937283350 K121190 000
40301937377011 K121190 000
40301937379015 K121190 000
40301937277359 K121190 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.